News

NUS scientists use AI platform to improve effectiveness of Covid-19 drugs against Omicron

Prof Dean Ho found that when antiviral drugs molnupiravir and Paxlovid were each combined with the protease-inhibiting drug YH-53, the mix was effective against the Omicron variant of the coronavirus in lab settings. He used his AI platform, known as IDentif.AI, to determine the combination and dosage.

Read more: https://www.straitstimes.com/singapore/nus-scientists-leverage-ai-platform-to-improve-effectiveness-of-covid-19-drugs-against-omicron

view MORE related

News

2025
npj Precision Oncology – Functional combinatorial precision medicine for predicting and optimizing soft tissue sarcoma treatments
More Details >
2025
Singapore’s Balancing Act – Trade-offs of a Global City-state
More Details >
2025
Scientists use microcellular drones to deliver lung cancer-killing drugs
More Details >
get in touch and

Contact Us

For inquiries pertaining to our R&D Programs, please contact Khew Si Ying at khewsiying@nus.edu.sg

The Institute for Digital Medicine (WisDM)

  • 28 Medical Drive, #05-COR,
    Singapore 117456

© National University of Singapore. All Rights Reserved.